{"id":76279,"date":"2026-10-15T21:20:05","date_gmt":"2026-10-15T21:20:05","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76279"},"modified":"2026-10-15T21:20:05","modified_gmt":"2026-10-15T21:20:05","slug":"us-analyst-updates-october-15th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/","title":{"rendered":"US Analyst Updates: October 15th, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/strong><\/a><\/h2>\n

American analyst sentiment for October 15, 2026, shows a cautious but selectively optimistic market outlook, with 136 price target reductions outpacing 92 increases, highlighting concerns over valuations, earnings growth, and economic uncertainty. However, 20 rating upgrades exceeded the 14 downgrades, suggesting continued confidence in select opportunities across energy, financials, healthcare, and technology. Overall, analysts remained positive toward companies with resilient earnings and strong fundamentals while adopting a more conservative outlook on broader market valuations.<\/p>\n

Updates:<\/strong><\/p>\n

A10 Networks (ATEN)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to US$30.00 from US$34.00.<\/p>\n

\n

Accenture (ACN)<\/strong> \u2014 Stifel Nicolaus set a US$242.00 price target.<\/p>\n<\/div>\n

Accenture (ACN)<\/strong> \u2014 Susquehanna maintained its Neutral rating and raised its price target to US$230.00 from US$210.00.<\/p>\n

Accenture (ACN)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$201.00 from US$193.00.<\/p>\n

Accenture (ACN)<\/strong> \u2014 UBS Group AG set a US$278.00 price target.<\/p>\n

AECOM (ACM)<\/strong> \u2014 KeyCorp maintained its Overweight rating and lowered its price target to US$78.00 from US$79.00.<\/p>\n

AECOM (ACM)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$89.00 from US$90.00.<\/p>\n

Aflac (AFL)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Outperform rating and raised its price target to US$11.00 from US$13.00.<\/p>\n

AG Mortgage Investment Trust (MITT)<\/strong> \u2014 Citigroup Inc. reiterated its Market Outperform rating.<\/p>\n

AG Mortgage Investment Trust (MITT)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to US$8.50 from US$9.25.<\/p>\n

Air Products and Chemicals (APD)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$346.00 from US$360.00.<\/p>\n

AIRO Group (AIRO)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to US$11.00 from US$13.00.<\/p>\n

Albemarle (ALB)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$129.00 from US$157.00.<\/p>\n

Albertsons (ACI)<\/strong> \u2014 Goldman downgraded its rating to Neutral from Buy with a US$13.00 price target.<\/p>\n

Albertsons Companies (ACI)<\/strong> \u2014 JPMorgan Chase & Co. downgraded its rating to Neutral from Overweight with a US$14.00 price target.<\/p>\n

Albertsons Companies (ACI)<\/strong> \u2014 The Goldman Sachs Group, Inc. downgraded its rating to Neutral from Buy with a US$13.00 price target.<\/p>\n

Align Technology (ALGN)<\/strong> \u2014 Robert W. Baird reiterated its rating to Neutral from Outperform and its price target to US$162.00 from US$218.00.<\/p>\n

Alnylam Pharmaceuticals (ALNY)<\/strong> \u2014 UBS Group AG initiated coverage with a Buy rating and a US$354.00 price target.<\/p>\n

Alphabet (GOOG)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$425.00 from US$420.00.<\/p>\n

Alphabet (GOOGL)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$425.00 from US$420.00.<\/p>\n

Alpine Income Property Trust (PINE)<\/strong> \u2014 Truist Financial Corporation maintained its Hold rating and lowered its price target to US$19.00 from US$20.00.<\/p>\n

AMC Networks (AMCX)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and lowered its price target to US$9.00 from US$10.00.<\/p>\n

American Axle & Manufacturing (DCH)<\/strong> \u2014 Bank of America Corporation downgraded its rating to Underperform from Buy with a US$5.00 price target.<\/p>\n

Amylyx Pharmaceuticals (AMLX)<\/strong> \u2014 Citigroup Inc. maintained its Buy rating and raised its price target to US$39.00 from US$32.00.<\/p>\n

AngloGold Ashanti (AU)<\/strong> \u2014 Goldman initiated coverage with a Reduce ? Buy rating and a US$104.00 price target.<\/p>\n

AngloGold Ashanti (AU)<\/strong> \u2014 The Goldman Sachs Group, Inc. initiated coverage with a Reduce ? Buy rating and a US$104.00 price target.<\/p>\n

Antero Resources (AR)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$51.00 from US$49.00.<\/p>\n

Antero Resources (AR)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Outperform rating and a US$46 price target.<\/p>\n

APA (APA)<\/strong> \u2014 Mizuho maintained its Underperform rating and raised its price target to US$44.00 from US$36.00.<\/p>\n

APA (APA)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to US$43.00 from US$41.00.<\/p>\n

APA (APA)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to US$49.00 from US$47.00.<\/p>\n

APA Corp. (APA)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$44 price target.<\/p>\n

Applied Industrial Technologies (AIT)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to US$390.00 from US$400.00.<\/p>\n

Applied Materials (AMAT)<\/strong> \u2014 Evercore Inc set a US$590.00 price target.<\/p>\n

Applied Optoelectronics (AAOI)<\/strong> \u2014 B. Riley Financial, Inc. maintained its Neutral rating and lowered its price target to US$92.00 from US$109.00.<\/p>\n

ArcelorMittal (MT)<\/strong> \u2014 JP Morgan upgraded its rating to Overweight from Neutral.<\/p>\n

Arcutis Biotherapeutics (ARQT)<\/strong> \u2014 Cantor Fitzgerald initiated coverage with a Overweight rating and a US$48.00 price target.<\/p>\n

Array Tech (ARRY)<\/strong> \u2014 Mizuho upgrade its Neutral \u00bb Outperform rating.<\/p>\n

Arrowhead Pharmaceuticals (ARWR)<\/strong> \u2014 Chardan Capital reiterated its Buy rating and a US$115.00 price target.<\/p>\n

Arrowhead Pharmaceuticals (ARWR)<\/strong> \u2014 HC Wainwright reiterated its Buy rating and a US$120.00 price target.<\/p>\n

Arrowhead Pharmaceuticals (ARWR)<\/strong> \u2014 UBS Group AG initiated coverage with a Buy rating and a US$109.00 price target.<\/p>\n

Ascendis Pharma A\/S (ASND)<\/strong> \u2014 UBS Group AG set a US$269.00 price target.<\/p>\n

ASML (ASML)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to US$2,350.00 from US$2,400.00.<\/p>\n

Atlas Energy Solutions (AESI)<\/strong> \u2014 Barclays PLC maintained its Equal Weight rating and lowered its price target to US$13.00 from US$14.00.<\/p>\n

Atlassian (TEAM)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to US$235.00 from US$215.00.<\/p>\n

Atmos Energy (ATO)<\/strong> \u2014 Truist Financial Corporation maintained its Hold rating and lowered its price target to US$174.00 from US$179.00.<\/p>\n

Axon Enterprise (AXON)<\/strong> \u2014 Raymond James Financial, Inc. set a US$675.00 price target.<\/p>\n

AZZ (AZZ)<\/strong> \u2014 B. Riley Financial, Inc. maintained its Buy rating and raised its price target to US$174.00 from US$170.00.<\/p>\n

AZZ (AZZ)<\/strong> \u2014 Barclays PLC maintained its Equal Weight rating and raised its price target to US$145.00 from US$140.00.<\/p>\n

AZZ (AZZ)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and lowered its price target to US$150.00 from US$155.00.<\/p>\n

AZZ (AZZ)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$145.00 from US$144.00.<\/p>\n

Bank of America (BAC)<\/strong> \u2014 Barclays PLC maintained its Overweight rating and lowered its price target to US$68.00 from US$72.00.<\/p>\n

Bank of America (BAC)<\/strong> \u2014 Citigroup Inc. maintained its Buy rating and lowered its price target to US$60.00 from US$66.00.<\/p>\n

Bank of America (BAC)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to US$65.00 from US$70.00.<\/p>\n

Bank of America (BAC)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$61.00 from US$67.00.<\/p>\n

Bank of America (BAC)<\/strong> \u2014 Robert W. Baird upgraded its rating to Outperform from Neutral with a US$62.00 price target.<\/p>\n

Bank of America (BAC)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$60.00 from US$65.00.<\/p>\n

Bank of America (BAC)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$56.00 from US$60.00.<\/p>\n

Bank of America (BAC)<\/strong> \u2014 Truist Financial Corporation maintained its Buy rating and lowered its price target to US$58.00 from US$62.00.<\/p>\n

Bank of America (BAC)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$64.00 from US$69.00.<\/p>\n

Beam Therapeutics (BEAM)<\/strong> \u2014 HC Wainwright reiterated its Buy rating and a US$80.00 price target.<\/p>\n

Beauty Health (SKIN)<\/strong> \u2014 Citigroup Inc. reiterated its Hold rating.<\/p>\n

Beauty Health (SKIN)<\/strong> \u2014 Stifel Nicolaus set a US$10.00 price target.<\/p>\n

Belite Bio (BLTE)<\/strong> \u2014 HC Wainwright reiterated its Buy rating and a US$245.00 price target.<\/p>\n

BellRing Brands (BRBR)<\/strong> \u2014 UBS Group AG set a US$9.50 price target.<\/p>\n

BioMarin Pharmaceutical (BMRN)<\/strong> \u2014 UBS Group AG initiated coverage with a Buy rating and a US$88.00 price target.<\/p>\n

Black Hills Corp (BKH)<\/strong> \u2014 Jefferies initiated coverage with a Buy rating and a US$87 price target.<\/p>\n

BlackRock (BLK)<\/strong> \u2014 Barclays PLC maintained its Overweight rating and lowered its price target to US$1,410.00 from US$1,420.00.<\/p>\n

BlackRock (BLK)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$1,449.00 from US$1,435.00.<\/p>\n

BlackRock (BLK)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to US$1,310.00 from US$1,290.00.<\/p>\n

BlackRock (BLK)<\/strong> \u2014 Truist Financial Corporation set a US$1,310.00 price target.<\/p>\n

BlackRock (BLK)<\/strong> \u2014 UBS Group AG reiterated its Buy rating and a US$1,300.00 price target.<\/p>\n

BlackRock (BLK)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$1,250.00 from US$1,230.00.<\/p>\n

Block (XYZ)<\/strong> \u2014 UBS Group AG set a US$96.00 price target.<\/p>\n

Bloom Energy (BE)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to US$351.00 from US$310.00.<\/p>\n

Boeing (BA)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$235.00 from US$265.00.<\/p>\n

BorgWarner (BWA)<\/strong> \u2014 Bank of America Corporation upgraded its rating to Buy from Neutral and set its price target to US$85.00 from US$78.00.<\/p>\n

BridgeBio Pharma (BBIO)<\/strong> \u2014 UBS Group AG set a US$92.00 price target.<\/p>\n

Bright Minds Biosciences (DRUG)<\/strong> \u2014 Wolfe Research initiated coverage with a Outperform rating and a US$150.00 price target.<\/p>\n

Brighthouse Financial (BHF)<\/strong> \u2014 JPMorgan Chase & Co. upgraded its rating to Neutral from Underweight and set its price target to US$55.00 from US$63.00.<\/p>\n

Brighthouse Financial (BHF)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to US$55.00 from US$57.00.<\/p>\n

Brookfield Business (BBUC)<\/strong> \u2014 RBC Dominion Securities maintained its Outperform rating and lowered its price target to US$34.00 from US$40.00.<\/p>\n

Brookfield Business (BBUC)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$34.00 from US$40.00.<\/p>\n

C.H. Robinson Worldwide (CHRW)<\/strong> \u2014 Raymond James Financial, Inc. reiterated its Outperform rating and a US$170.00 price target.<\/p>\n

Cactus (WHD)<\/strong> \u2014 Barclays PLC maintained its Overweight rating and raised its price target to US$75.00 from US$74.00.<\/p>\n

CAMP4 Therapeutics (CAMP)<\/strong> \u2014 Needham & Company LLC initiated coverage with a Neutral ? Buy rating and a US$8.00 price target.<\/p>\n

CarMax (KMX)<\/strong> \u2014 Bank of America Corporation upgraded its rating to Buy from Underperform and set its price target to US$65.00 from US$50.00.<\/p>\n

CarMax (KMX)<\/strong> \u2014 UBS Group AG set a US$65.00 price target.<\/p>\n

Carrier Global (CARR)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to US$70.00 from US$75.00.<\/p>\n

Carvana (CVNA)<\/strong> \u2014 Morgan Stanley set its price target to US$88.00 from US$90.00.<\/p>\n

Casey’s General Stores (CASY)<\/strong> \u2014 Royal Bank Of Canada upgraded its rating to Outperform from Sector Perform and set its price target to US$825.00 from US$910.00.<\/p>\n

CCC Intelligent Solutions Holdings Inc. Common Stock (CCC)<\/strong> \u2014 William Blair downgraded its Market Perform rating.<\/p>\n

Celsius (CELH)<\/strong> \u2014 UBS Group AG set a US$38.00 price target.<\/p>\n

Cemex (CX)<\/strong> \u2014 Citigroup Inc. upgraded its rating to Buy from Neutral and set its price target to US$12.00 from US$13.70.<\/p>\n

Champion Homes (SKY)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$94.00 from US$99.00.<\/p>\n

Charles Schwab (SCHW)<\/strong> \u2014 Evercore Inc reiterated its Underperform rating.<\/p>\n

Check Point Software Technologies (CHKP)<\/strong> \u2014 Mizuho maintained its Neutral rating and raised its price target to US$145.00 from US$135.00.<\/p>\n

Check Point Software Technologies (CHKP)<\/strong> \u2014 UBS Group AG reiterated its Neutral rating and a US$145.00 price target.<\/p>\n

Cheesecake Factory (CAKE)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$87.00 from US$80.00.<\/p>\n

Cheesecake Factory (CAKE)<\/strong> \u2014 Stephens maintained its Equal Weight rating and raised its price target to US$100.00 from US$93.00.<\/p>\n

Chefs’ Warehouse (CHEF)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$120.00 from US$104.00.<\/p>\n

Cheniere Energy (LNG)<\/strong> \u2014 Scotiabank set a US$311.00 price target.<\/p>\n

Chevron (CVX)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$226.00 from US$218.00.<\/p>\n

Chipotle Mexican Grill (CMG)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$40.00 from US$39.00.<\/p>\n

Chipotle Mexican Grill (CMG)<\/strong> \u2014 Stephens maintained its Equal Weight rating and lowered its price target to US$38.00 from US$40.00.<\/p>\n

Chord Energy (CHRD)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$178.00 from US$169.00.<\/p>\n

Chord Energy (CHRD)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Outperform rating and a US$192 price target.<\/p>\n

Church & Dwight (CHD)<\/strong> \u2014 UBS Group AG reiterated its Neutral rating and a US$106.00 price target.<\/p>\n

Cirrus Logic (CRUS)<\/strong> \u2014 KeyBanc Capital Markets downgrade its Overweight \u00bb Sector Weight rating.<\/p>\n

Clarivate (CLVT)<\/strong> \u2014 William Blair downgraded its Market Perform rating.<\/p>\n

Clean Harbors (CLH)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating and a US$364.00 price target.<\/p>\n

Clorox (CLX)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$87.00 from US$97.00.<\/p>\n

Clorox (CLX)<\/strong> \u2014 UBS Group AG set a US$91.00 price target.<\/p>\n

CNX Resources (CNX)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to US$38.00 from US$42.00.<\/p>\n

CNX Resources (CNX)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to US$34.00 from US$32.00.<\/p>\n

CNX Resources (CNX)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$34 price target.<\/p>\n

Colgate-Palmolive (CL)<\/strong> \u2014 UBS Group AG set a US$106.00 price target.<\/p>\n

Colliers International Group (CIGI)<\/strong> \u2014 National Bank Financial maintained its Outperform rating and lowered its price target to US$109.00 from US$110.00.<\/p>\n

Comfort Systems USA (FIX)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to US$2,125.00 from US$2,110.00.<\/p>\n

Comfort Systems USA (FIX)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to US$2,125.00 from US$2,110.00.<\/p>\n

CommVault Systems (CVLT)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to US$185.00 from US$175.00.<\/p>\n

Comstock Resources (CRK)<\/strong> \u2014 Morgan Stanley set its price target to US$13.00 from US$15.00.<\/p>\n

Comtech Telecommunications (CMTL)<\/strong> \u2014 B. Riley Financial, Inc. maintained its Buy rating and lowered its price target to US$4.75 from US$6.00.<\/p>\n

ConocoPhillips (COP)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$159.00 from US$151.00.<\/p>\n

Contineum Therapeutics (CTNM)<\/strong> \u2014 JonesTrading maintained its Buy rating and raised its price target to US$30.00 from US$24.00.<\/p>\n

Core Scientific (CORZ)<\/strong> \u2014 BTIG Research reiterated its Buy rating and a US$38.00 price target.<\/p>\n

Core Scientific (CORZ)<\/strong> \u2014 Canaccord Genuity Group Inc. reiterated its Buy rating and a US$36.00 price target.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to US$88.00 from US$115.00.<\/p>\n

Credo Technology Group (CRDO)<\/strong> \u2014 Rosenblatt Securities reiterated its Neutral rating and a US$235.00 price target.<\/p>\n

Crescent Energy (CRGY)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Outperform rating and a US$18 price target.<\/p>\n

CRISPR Therapeutics (CRSP)<\/strong> \u2014 UBS Group AG initiated coverage with a Buy ? Neutral rating and a US$52.00 price target.<\/p>\n

Crocs (CROX)<\/strong> \u2014 Barclays upgraded its rating to Overweight from Equal Weight and set its price target to US$139.00 from US$118.00.<\/p>\n

Crocs (CROX)<\/strong> \u2014 Barclays PLC upgraded its rating to Overweight from Equal Weight and set its price target to US$139.00 from US$118.00.<\/p>\n

CSX (CSX)<\/strong> \u2014 Raymond James Financial, Inc. reiterated its Outperform rating and a US$53.00 price target.<\/p>\n

D.R. Horton (DHI)<\/strong> \u2014 Citigroup Inc. maintained its Neutral rating and lowered its price target to US$150.00 from US$160.00.<\/p>\n

D.R. Horton (DHI)<\/strong> \u2014 Royal Bank Of Canada maintained its Underperform rating and lowered its price target to US$119.00 from US$125.00.<\/p>\n

Darling Ingredients (DAR)<\/strong> \u2014 Stephens reiterated its Overweight rating and a US$80.00 price target.<\/p>\n

Datadog (DDOG)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to US$330.00 from US$300.00.<\/p>\n

Deckers Outdoor (DECK)<\/strong> \u2014 Telsey Advisory Group reiterated its Market Perform rating and a US$105.00 price target.<\/p>\n

Deckers Outdoor (DECK)<\/strong> \u2014 UBS Group AG reiterated its Buy rating and a US$140.00 price target.<\/p>\n

Delek US (DK)<\/strong> \u2014 The Goldman Sachs Group, Inc. maintained its Buy rating and raised its price target to US$97.00 from US$83.00.<\/p>\n

Devon Energy (DVN)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$65.00 from US$63.00.<\/p>\n

Devon Energy (DVN)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Outperform rating and a US$61 price target.<\/p>\n

Diamondback Energy (FANG)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$222.00 from US$216.00.<\/p>\n

Diamondback Energy (FANG)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Outperform rating and a US$250 price target.<\/p>\n

Dianthus Therapeutics (DNTH)<\/strong> \u2014 HC Wainwright reiterated its Buy rating and a US$158.00 price target.<\/p>\n

Diebold Nixdorf (DBD)<\/strong> \u2014 Wedbush reiterated its Outperform rating and a US$100.00 price target.<\/p>\n

Digital Turbine (APPS)<\/strong> \u2014 Roth Capital initiated coverage with a Buy rating and a US$19.00 price target.<\/p>\n

Domino’s Pizza (DPZ)<\/strong> \u2014 Sanford C. Bernstein reiterated its Market Perform rating.<\/p>\n

Dover (DOV)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to US$245.00 from US$270.00.<\/p>\n

DT Midstream (DTM)<\/strong> \u2014 Jefferies Financial Group Inc. reiterated its Buy rating and a US$150.00 price target.<\/p>\n

DT Midstream (DTM)<\/strong> \u2014 Scotiabank set a US$165.00 price target.<\/p>\n

DuPont de Nemours (DD)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$160.00 from US$176.00.<\/p>\n

Dutch Bros (BROS)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$71.00 from US$88.00.<\/p>\n

Dutch Bros (BROS)<\/strong> \u2014 Stephens maintained its Overweight rating and lowered its price target to US$65.00 from US$80.00.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 The Goldman Sachs Group, Inc. reiterated its Buy rating and a US$71.00 price target.<\/p>\n

e.l.f. Beauty (ELF)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$103.00 from US$90.00.<\/p>\n

e.l.f. Beauty (ELF)<\/strong> \u2014 UBS Group AG reiterated its Neutral rating and a US$116.00 price target.<\/p>\n

Edgewell Personal Care (EPC)<\/strong> \u2014 UBS Group AG reiterated its Neutral rating and a US$30.00 price target.<\/p>\n

Edison International (EIX)<\/strong> \u2014 The Goldman Sachs Group, Inc. set a US$67.00 price target.<\/p>\n

Eloxx Pharmaceuticals (ELOX)<\/strong> \u2014 Cantor Fitzgerald initiated coverage with a Overweight rating.<\/p>\n

Emerson Electric (EMR)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to US$180.00 from US$173.00.<\/p>\n

Enel Chile (ENIC)<\/strong> \u2014 Bank of America Corporation initiated coverage with a Neutral rating.<\/p>\n

Energizer (ENR)<\/strong> \u2014 UBS Group AG set a US$22.00 price target.<\/p>\n

Envista (NVST)<\/strong> \u2014 Robert W. Baird reiterated its rating to Neutral from Outperform and its price target to US$26.00 from US$34.00.<\/p>\n

EOG Resources (EOG)<\/strong> \u2014 Mizuho set a US$165.00 price target.<\/p>\n

EOG Resources (EOG)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$163.00 from US$157.00.<\/p>\n

EOG Resources (EOG)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$144 price target.<\/p>\n

EQT (EQT)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to US$68.00 from US$72.00.<\/p>\n

EQT Corp. (EQT)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$54 price target.<\/p>\n

Establishment Labs (ESTA)<\/strong> \u2014 Stifel initiated coverage with a Buy rating and a US$85 price target.<\/p>\n

Establishment Labs (ESTA)<\/strong> \u2014 TD Cowen reiterated its Buy rating and a US$117.00 price target.<\/p>\n

Estee Lauder Companies (EL)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$112.00 from US$102.00.<\/p>\n

Eton Pharmaceuticals (ETON)<\/strong> \u2014 Craig Hallum reiterated its Buy rating and a US$78.00 price target.<\/p>\n

Expand Energy (EXE)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$124.00 from US$129.00.<\/p>\n

Expand Energy (EXE)<\/strong> \u2014 UBS Group AG set a US$120.00 price target.<\/p>\n

ExxonMobil (XOM)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$185.00 from US$177.00.<\/p>\n

EZCORP (EZPW)<\/strong> \u2014 Canaccord Genuity Group Inc. maintained its Buy rating and raised its price target to US$45.00 from US$44.00.<\/p>\n

Fabrinet (FN)<\/strong> \u2014 B. Riley Financial, Inc. maintained its Neutral rating and lowered its price target to US$431.00 from US$598.00.<\/p>\n

Fastenal (FAST)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to US$60.00 from US$59.00.<\/p>\n

Fastenal (FAST)<\/strong> \u2014 Sanford C. Bernstein reiterated its Underperform rating and its price target to US$47.00 from US$42.00.<\/p>\n

FedEx Freight (FDXF)<\/strong> \u2014 Raymond James Financial, Inc. reiterated its Outperform rating and a US$165.00 price target.<\/p>\n

Fidelity National Financial (FNF)<\/strong> \u2014 Truist Financial Corporation maintained its Buy rating and lowered its price target to US$59.00 from US$70.00.<\/p>\n

Fidelity National Information Services (FIS)<\/strong> \u2014 Bank of America Corporation initiated coverage with a Buy rating and a US$42.00 price target.<\/p>\n

First American Financial (FAF)<\/strong> \u2014 Truist Financial Corporation maintained its Buy rating and lowered its price target to US$80.00 from US$85.00.<\/p>\n

First Financial Bankshares (FFIN)<\/strong> \u2014 Raymond James initiated coverage with a Mkt Perform rating and a — price target.<\/p>\n

First Solar (FSLR)<\/strong> \u2014 Barclays PLC maintained its Overweight rating and lowered its price target to US$259.00 from US$279.00.<\/p>\n

First Watch Restaurant Group (FWRG)<\/strong> \u2014 Stephens maintained its Overweight rating and lowered its price target to US$18.00 from US$21.00.<\/p>\n

FirstCash (FCFS)<\/strong> \u2014 Canaccord Genuity Group Inc. maintained its Buy rating and raised its price target to US$265.00 from US$252.00.<\/p>\n

FirstService (FSV)<\/strong> \u2014 Canadian Imperial Bank of Commerce set a US$170.00 price target.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 Bank of America Corporation initiated coverage with a Underperform rating and a US$48.00 price target.<\/p>\n

Fiverr International (FVRR)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to US$10.00 from US$11.00.<\/p>\n

Flowserve (FLS)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to US$85.00 from US$91.00.<\/p>\n

FMC (FMC)<\/strong> \u2014 Barclays PLC reiterated its Underweight rating and a US$4.00 price target.<\/p>\n

FMC (FMC)<\/strong> \u2014 Mizuho set a US$10.00 price target.<\/p>\n

FMC (FMC)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$9.00 from US$11.00.<\/p>\n

Fortinet (FTNT)<\/strong> \u2014 Mizuho set its price target to US$160.00 from US$138.00.<\/p>\n

Fortinet (FTNT)<\/strong> \u2014 UBS Group AG reiterated its Neutral rating and a US$200.00 price target.<\/p>\n

Fortinet (FTNT)<\/strong> \u2014 Wells Fargo & Company maintained its Underweight rating and raised its price target to US$160.00 from US$135.00.<\/p>\n

Fortrea (FTRE)<\/strong> \u2014 Deutsche Bank upgraded its rating to Buy from Hold and set its price target to US$25.00 from US$20.00.<\/p>\n

Fortrea (FTRE)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft upgraded its rating to Buy from Hold and set its price target to US$25.00 from US$20.00.<\/p>\n

General Dynamics (GD)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$360.00 from US$410.00.<\/p>\n

GFL Environmental (GFL)<\/strong> \u2014 BMO Capital Markets reiterated its Market Perform rating.<\/p>\n

GFL Environmental (GFL)<\/strong> \u2014 Scotiabank set its price target to US$55.00 from US$57.00.<\/p>\n

Global Payments (GPN)<\/strong> \u2014 Bank of America Corporation initiated coverage with a Buy rating and a US$114.00 price target.<\/p>\n

GlobalFoundries (GFS)<\/strong> \u2014 TD Cowen reiterated its Buy rating and a US$75.00 price target.<\/p>\n

GlobalFoundries (GFS)<\/strong> \u2014 Wedbush reiterated its Neutral rating and a US$72.00 price target.<\/p>\n

Globe Life (GL)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$195.00 from US$193.00.<\/p>\n

Gold Fields (GFI)<\/strong> \u2014 Goldman initiated coverage with a Neutral rating and a US$38.00 price target.<\/p>\n

Gold Fields (GFI)<\/strong> \u2014 The Goldman Sachs Group, Inc. initiated coverage with a Neutral rating and a US$38.00 price target.<\/p>\n

GrafTech International (EAF)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to US$8.00 from US$7.00.<\/p>\n

Gulfport Energy (GPOR)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Outperform rating and a US$217 price target.<\/p>\n

Harmony Biosciences (HRMY)<\/strong> \u2014 LADENBURG THALM\/SH SH initiated coverage with a Buy rating and a US$55.00 price target.<\/p>\n

Harmony Biosciences (HRMY)<\/strong> \u2014 Ladenburg Thalmann initiated coverage with a Buy rating and a US$55 price target.<\/p>\n

HawkEye 360 (HAWK)<\/strong> \u2014 Piper Sandler initiated coverage with a Overweight rating and a US$22 price target.<\/p>\n

Hemab Therapeutics (COAG)<\/strong> \u2014 JPMorgan Chase & Co. initiated coverage with a Overweight rating and a US$70.00 price target.<\/p>\n

Hershey (HSY)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to US$183.00 from US$193.00.<\/p>\n

Hershey (HSY)<\/strong> \u2014 UBS Group AG set a US$178.00 price target.<\/p>\n

Hexcel (HXL)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$105.00 from US$115.00.<\/p>\n

Hilton Grand Vacations (HGV)<\/strong> \u2014 Susquehanna maintained its Neutral rating and lowered its price target to US$39.00 from US$50.00.<\/p>\n

Honeywell Aerospace (HONA)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$210.00 from US$250.00.<\/p>\n

Honeywell International (HON)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to US$255.00 from US$265.00.<\/p>\n

Howmet Aerospace (HWM)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$300.00 from US$350.00.<\/p>\n

Hubbell (HUBB)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to US$560.00 from US$575.00.<\/p>\n

IMAX (IMAX)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$55.00 from US$45.00.<\/p>\n

ImmunityBio (IBRX)<\/strong> \u2014 HC Wainwright reiterated its Buy rating and a US$15.00 price target.<\/p>\n

Infinity Natural Resources (INR)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Outperform rating and a US$17 price target.<\/p>\n

Infleqtion (INFQ)<\/strong> \u2014 Morgan Stanley set a US$12.00 price target.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$238.00 from US$190.00.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 UBS Group AG initiated coverage with a Neutral ? Buy rating and a US$88.00 price target.<\/p>\n

IonQ (IONQ)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$43.00 from US$49.00.<\/p>\n

J. M. Smucker (SJM)<\/strong> \u2014 Sanford C. Bernstein maintained its Outperform rating and raised its price target to US$160.00 from US$157.00.<\/p>\n

Jack Henry & Associates (JKHY)<\/strong> \u2014 Bank of America Corporation initiated coverage with a Neutral rating and a US$165.00 price target.<\/p>\n

Jack In The Box (JACK)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$14.00 from US$15.00.<\/p>\n

Jacobs Solutions (J)<\/strong> \u2014 KeyCorp lowered .<\/p>\n

Johnson & Johnson (JNJ)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$292.00 from US$294.00.<\/p>\n

Johnson & Johnson (JNJ)<\/strong> \u2014 Sanford C. Bernstein set a US$270.00 price target.<\/p>\n

Johnson Controls International (JCI)<\/strong> \u2014 Mizuho maintained its Neutral rating and raised its price target to US$165.00 from US$150.00.<\/p>\n

JPMorgan Chase & Co. (JPM)<\/strong> \u2014 Citigroup Inc. maintained its Neutral rating and lowered its price target to US$350.00 from US$360.00.<\/p>\n

KB Home (KBH)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$47.00 from US$50.00.<\/p>\n

Kinetik (KNTK)<\/strong> \u2014 Scotiabank reiterated its Outperform rating and a US$59.00 price target.<\/p>\n

Krystal Biotech (KRYS)<\/strong> \u2014 HC Wainwright reiterated its Buy rating and a US$361.00 price target.<\/p>\n

Kura Sushi USA (KRUS)<\/strong> \u2014 DA Davidson maintained its Buy rating and lowered its price target to US$55.00 from US$65.00.<\/p>\n

L3Harris Technologies (LHX)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$265.00 from US$310.00.<\/p>\n

Laureate Education (LAUR)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to US$36.50 from US$34.50.<\/p>\n

Lennox International (LII)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to US$395.00 from US$450.00.<\/p>\n

Lennox International (LII)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and lowered its price target to US$350.00 from US$375.00.<\/p>\n

Levi Strauss & Co. (LEVI)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$23.00 from US$28.00.<\/p>\n

LGN (LGN)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$90.00 from US$101.00.<\/p>\n

Lincoln National (LNC)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Underweight rating and lowered its price target to US$47.00 from US$49.00.<\/p>\n

Linde (LIN)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$549.00 from US$553.00.<\/p>\n

Lineage (LINE)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Underweight rating and lowered its price target to US$37.00 from US$40.00.<\/p>\n

Liquidia (LQDA)<\/strong> \u2014 HC Wainwright maintained its Buy rating and raised its price target to US$65.00 from US$58.00.<\/p>\n

Liquidia (LQDA)<\/strong> \u2014 Royal Bank Of Canada set a US$65.00 price target.<\/p>\n

Lithium Americas (LAC)<\/strong> \u2014 Canaccord Genuity upgraded its rating to Speculative Buy from Hold.<\/p>\n

Lithium Americas (LAC)<\/strong> \u2014 Canaccord Genuity Group Inc. upgraded its rating to Speculative Buy from Hold.<\/p>\n

Lockheed Martin (LMT)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$550.00 from US$600.00.<\/p>\n

Lucid Group (LCID)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and lowered its price target to US$3.00 from US$5.00.<\/p>\n

Magna International (MGA)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$68.00 from US$69.00.<\/p>\n

Magnolia Oil & Gas (MGY)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Outperform rating and a US$31 price target.<\/p>\n

Magnolia Oil & Gas (MGY)<\/strong> \u2014 UBS Group AG set a US$35.00 price target.<\/p>\n

Marriott Vacations Worldwide (VAC)<\/strong> \u2014 Susquehanna maintained its Neutral rating and raised its price target to US$115.00 from US$110.00.<\/p>\n

MasTec (MTZ)<\/strong> \u2014 KeyCorp maintained its Overweight rating and lowered its price target to US$320.00 from US$371.00.<\/p>\n

Mastercard (MA)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating and a US$665.00 price target.<\/p>\n

Matador Resources (MTDR)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$69.00 from US$66.00.<\/p>\n

Matador Resources (MTDR)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$59.00 price target.<\/p>\n

MetLife (MET)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$110.00 from US$108.00.<\/p>\n

MFA Financial (MFA)<\/strong> \u2014 Citigroup Inc. reiterated its Market Outperform rating.<\/p>\n

MFA Financial (MFA)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to US$8.00 from US$11.00.<\/p>\n

MGE Energy (MGEE)<\/strong> \u2014 JPMorgan Chase & Co. initiated coverage with a Neutral rating and a US$76.00 price target.<\/p>\n

Microsoft (MSFT)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to US$600.00 from US$510.00.<\/p>\n

Microsoft (MSFT)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$625.00 from US$540.00.<\/p>\n

Microsoft (MSFT)<\/strong> \u2014 UBS Group AG reiterated its Buy rating and a US$675.00 price target.<\/p>\n

Mobileye Global (MBLY)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$9.00 from US$10.00.<\/p>\n

Moderna (MRNA)<\/strong> \u2014 The Goldman Sachs Group, Inc. maintained its Neutral rating and raised its price target to US$137.00 from US$120.00.<\/p>\n

Morgan Stanley (MS)<\/strong> \u2014 Citigroup Inc. maintained its Neutral rating and lowered its price target to US$190.00 from US$210.00.<\/p>\n

Morgan Stanley (MS)<\/strong> \u2014 Keefe, Bruyette & Woods reiterated its Outperform rating and its price target to US$230.00 from US$250.00.<\/p>\n

Morgan Stanley (MS)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$195.00 from US$243.00.<\/p>\n

Morgan Stanley (MS)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$205.00 from US$210.00.<\/p>\n

Morgan Stanley (MS)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$217.00 from US$223.00.<\/p>\n

Murphy Oil (MUR)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to US$37.00 from US$36.00.<\/p>\n

Murphy Oil (MUR)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$41 price target.<\/p>\n

Murphy USA (MUSA)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$612.00 from US$619.00.<\/p>\n

National Bank (NBHC)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$45.00 from US$49.00.<\/p>\n

National Energy Services Reunited (NESR)<\/strong> \u2014 Barclays PLC maintained its Overweight rating and lowered its price target to US$41.00 from US$45.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Jefferies set a US$85.00 price target.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Jefferies Financial Group Inc. set a US$85.00 price target.<\/p>\n

Netskope (NTSK)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$22.00 from US$17.00.<\/p>\n

NewJersey Resources (NJR)<\/strong> \u2014 Raymond James Financial, Inc. set a US$61.00 price target.<\/p>\n

Nextpower (NXT)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to US$101.00 from US$111.00.<\/p>\n

Northern Oil & Gas (NOG)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$27 price target.<\/p>\n

Northern Oil and Gas (NOG)<\/strong> \u2014 Morgan Stanley reiterated its Underweight rating and its price target to US$26.00 from US$25.00.<\/p>\n

NorthWestern (NWE)<\/strong> \u2014 Jefferies initiated coverage with a Buy rating and a US$85.00 price target.<\/p>\n

NorthWestern (NWE)<\/strong> \u2014 Jefferies Financial Group Inc. initiated coverage with a Buy rating and a US$85.00 price target.<\/p>\n

Novavax (NVAX)<\/strong> \u2014 Citigroup Inc. reiterated its Sell rating and its price target to US$8.00 from US$7.00.<\/p>\n

NRx Pharmaceuticals (NRXP)<\/strong> \u2014 Wolfe Research initiated coverage with a Outperform rating.<\/p>\n

Occidental Petroleum (OXY)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$71.00 from US$69.00.<\/p>\n

Occidental Petroleum (OXY)<\/strong> \u2014 Truist Financial Corporation maintained its Hold rating and raised its price target to US$64.00 from US$63.00.<\/p>\n

ODDITY Tech (ODD)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$18.50 from US$16.50.<\/p>\n

Okta (OKTA)<\/strong> \u2014 Citigroup Inc. maintained its Neutral rating and raised its price target to US$215.00 from US$205.00.<\/p>\n

ONEOK (OKE)<\/strong> \u2014 Scotiabank reiterated its Sector Perform rating and a US$96.00 price target.<\/p>\n

OppFi (OPFI)<\/strong> \u2014 Citigroup Inc. reiterated its Market Outperform rating.<\/p>\n

Ovid Therapeutics (OVID)<\/strong> \u2014 Wolfe Research initiated coverage with a Outperform rating and a US$5.00 price target.<\/p>\n

Ovintiv (OVV)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$71.00 from US$67.00.<\/p>\n

Pacific Gas & Electric (PCG)<\/strong> \u2014 The Goldman Sachs Group, Inc. set a US$20.00 price target.<\/p>\n

Palantir Technologies (PLTR)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to US$245.00 from US$215.00.<\/p>\n

Palo Alto Networks (PANW)<\/strong> \u2014 Citigroup Inc. reiterated its Buy rating and its price target to US$440.00 from US$410.00.<\/p>\n

Papa John’s International (PZZA)<\/strong> \u2014 Stephens maintained its Equal Weight rating and lowered its price target to US$19.00 from US$24.00.<\/p>\n

Par Pacific (PARR)<\/strong> \u2014 Goldman downgraded its rating to Neutral from Buy and set its price target to US$94.00 from US$90.00.<\/p>\n

Par Pacific (PARR)<\/strong> \u2014 The Goldman Sachs Group, Inc. downgraded its rating to Neutral from Buy and set its price target to US$94.00 from US$90.00.<\/p>\n

Parker-Hannifin (PH)<\/strong> \u2014 Mizuho set a US$1,200.00 price target.<\/p>\n

PayPal (PYPL)<\/strong> \u2014 BofA Securities resumed coverage with a Underperform rating and a — price target.<\/p>\n

Pegasystems (PEGA)<\/strong> \u2014 Rosenblatt Securities reiterated its Buy rating and a US$47.00 price target.<\/p>\n

PennyMac Mortgage Investment Trust (PMT)<\/strong> \u2014 Citigroup Inc. reiterated its Market Outperform rating.<\/p>\n

PennyMac Mortgage Investment Trust (PMT)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to US$12.50 from US$15.00.<\/p>\n

Pentair (PNR)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to US$65.00 from US$85.00.<\/p>\n

Performance Food Group (PFGC)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$136.00 from US$131.00.<\/p>\n

Performance Food Group (PFGC)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$110.00 from US$115.00.<\/p>\n

Permian Resources (PR)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$27.00 from US$25.00.<\/p>\n

Permian Resources (PR)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Outperform rating and a US$29 price target.<\/p>\n

Pershing Square (PS)<\/strong> \u2014 Wells Fargo & Company maintained its Underweight rating and lowered its price target to US$40.00 from US$41.00.<\/p>\n

Plains All American Pipeline (PAA)<\/strong> \u2014 Scotiabank reiterated its Outperform rating and a US$28.00 price target.<\/p>\n

Portillo’s (PTLO)<\/strong> \u2014 Stephens reiterated its Equal Weight rating and a US$5.00 price target.<\/p>\n

Post (POST)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to US$100.00 from US$125.00.<\/p>\n

Praxis Precision Medicines (PRAX)<\/strong> \u2014 HC Wainwright reiterated its Buy rating and a US$1,201.00 price target.<\/p>\n

Praxis Precision Medicines (PRAX)<\/strong> \u2014 UBS initiated coverage with a Buy rating and a US$706 price target.<\/p>\n

Principal Financial Group (PFG)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to US$106.00 from US$107.00.<\/p>\n

Proficient Auto Logistics (PAL)<\/strong> \u2014 Raymond James Financial, Inc. set a US$9.00 price target.<\/p>\n

Progressive (PGR)<\/strong> \u2014 BMO Capital Markets reiterated its Market Perform rating.<\/p>\n

Progressive (PGR)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to US$246.00 from US$252.00.<\/p>\n

Progressive (PGR)<\/strong> \u2014 Wells Fargo & Company maintained its Underweight rating and lowered its price target to US$196.00 from US$201.00.<\/p>\n

ProPetro (PUMP)<\/strong> \u2014 Barclays PLC maintained its Overweight rating and lowered its price target to US$17.00 from US$18.00.<\/p>\n

Protara Therapeutics (TARA)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to US$127.00 from US$131.00.<\/p>\n

PTC Therapeutics (PTCT)<\/strong> \u2014 UBS Group AG set a US$90.00 price target.<\/p>\n

Public Service Enterprise Group (PEG)<\/strong> \u2014 Truist Financial Corporation maintained its Hold rating and lowered its price target to US$78.00 from US$84.00.<\/p>\n

PulteGroup (PHM)<\/strong> \u2014 Citigroup Inc. maintained its Neutral rating and lowered its price target to US$122.00 from US$134.00.<\/p>\n

PulteGroup (PHM)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$111.00 from US$116.00.<\/p>\n

Qnity Electronics (Q)<\/strong> \u2014 Royal Bank Of Canada lowered .<\/p>\n

Quaker Houghton (KWR)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and raised its price target to US$202.00 from US$198.00.<\/p>\n

Quantinuum (QNT)<\/strong> \u2014 Morgan Stanley upgraded its rating to Overweight from Equal Weight and set its price target to US$62.00 from US$78.00.<\/p>\n

QuantumScape (QS)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$4.50 from US$8.50.<\/p>\n

Range Resources (RRC)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$45.00 from US$43.00.<\/p>\n

Rapid7 (RPD)<\/strong> \u2014 Mizuho maintained its Neutral rating and raised its price target to US$13.00 from US$11.00.<\/p>\n

Rapport Therapeutics (RAPP)<\/strong> \u2014 UBS Group AG initiated coverage with a Strong-Buy ? Buy rating and a US$71.00 price target.<\/p>\n

Rapport Therapeutics (RAPP)<\/strong> \u2014 Wolfe Research initiated coverage with a Outperform rating and a US$50.00 price target.<\/p>\n

RB Global (RBA)<\/strong> \u2014 National Bank Financial maintained its Outperform rating and raised its price target to US$132.00 from US$130.00.<\/p>\n

Redwire (RDW)<\/strong> \u2014 Piper Sandler initiated coverage with a Neutral rating and a US$11.00 price target.<\/p>\n

Redwood Trust (RWT)<\/strong> \u2014 Citigroup Inc. reiterated its Market Outperform rating.<\/p>\n

Redwood Trust (RWT)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to US$4.00 from US$6.00.<\/p>\n

Reinsurance Group of America (RGA)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$297.00 from US$293.00.<\/p>\n

Republic Services (RSG)<\/strong> \u2014 BMO Capital Markets set a US$244.00 price target.<\/p>\n

Republic Services (RSG)<\/strong> \u2014 Scotiabank reiterated its Sector Perform rating and a US$236.00 price target.<\/p>\n

Restaurant Brands International (QSR)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$82.00 from US$79.00.<\/p>\n

Revolution Medicines (RVMD)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating and a US$275.00 price target.<\/p>\n

Reynolds Consumer Products (REYN)<\/strong> \u2014 Barclays PLC maintained its Equal Weight rating and lowered its price target to US$23.00 from US$26.00.<\/p>\n

Rezolute (RZLT)<\/strong> \u2014 Citigroup Inc. reiterated its Market Outperform rating.<\/p>\n

Rhythm Pharmaceuticals (RYTM)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to US$145.00 from US$146.00.<\/p>\n

Rocket Lab (RKLB)<\/strong> \u2014 Cantor Fitzgerald reiterated its Mixed rating and a US$122.00 price target.<\/p>\n

Rocket Lab (RKLB)<\/strong> \u2014 KeyCorp maintained its Overweight rating and lowered its price target to US$100.00 from US$135.00.<\/p>\n

Rocket Lab (RKLB)<\/strong> \u2014 TD Cowen reiterated its Buy rating and a US$90.00 price target.<\/p>\n

Rockwell Automation (ROK)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to US$430.00 from US$445.00.<\/p>\n

Rollins (ROL)<\/strong> \u2014 Citigroup Inc. maintained its Neutral rating and lowered its price target to US$32.00 from US$46.00.<\/p>\n

RTX (RTX)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$235.00 from US$250.00.<\/p>\n

RTX (RTX)<\/strong> \u2014 Sanford C. Bernstein maintained its Market Perform rating and lowered its price target to US$214.00 from US$223.00.<\/p>\n

RXO, Inc. (RXO)<\/strong> \u2014 Citizens downgraded its rating to Market Perform from Outperform.<\/p>\n

Saia (SAIA)<\/strong> \u2014 Raymond James Financial, Inc. reiterated its Outperform rating and a US$410.00 price target.<\/p>\n

Scotts Miracle-Gro (SMG)<\/strong> \u2014 UBS Group AG upgraded its rating to Buy from Neutral with a US$70.00 price target.<\/p>\n

ServiceNow (NOW)<\/strong> \u2014 Mizuho set its price target to US$170.00 from US$140.00.<\/p>\n

ServiceNow (NOW)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$165.00 from US$140.00.<\/p>\n

Shake Shack (SHAK)<\/strong> \u2014 Guggenheim reiterated its Buy rating and a US$90.00 price target.<\/p>\n

Shake Shack (SHAK)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$79.00 from US$74.00.<\/p>\n

Shift4 Payments (FOUR)<\/strong> \u2014 Bank of America Corporation initiated coverage with a Neutral rating and a US$42.00 price target.<\/p>\n

Siemens AG (SIEGY)<\/strong> \u2014 Jefferies downgrade its Buy \u00bb Hold rating.<\/p>\n

Sight Sciences (SGHT)<\/strong> \u2014 HC Wainwright initiated coverage with a Buy rating and a US$14.00 price target.<\/p>\n

SLB (SLB)<\/strong> \u2014 Barclays PLC maintained its Overweight rating and lowered its price target to US$66.00 from US$67.00.<\/p>\n

SM Energy (SM)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$39 price target.<\/p>\n

Smith Douglas Homes (SDHC)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$10.00 from US$15.00.<\/p>\n

Solid Biosciences (SLDB)<\/strong> \u2014 UBS initiated coverage with a Buy rating and a US$20 price target.<\/p>\n

SOLV Energy (MWH)<\/strong> \u2014 KeyCorp maintained its Overweight rating and lowered its price target to US$35.00 from US$43.00.<\/p>\n

Southern (SO)<\/strong> \u2014 Truist Financial Corporation maintained its Hold rating and lowered its price target to US$93.00 from US$97.00.<\/p>\n

Spectrum Brands (SPB)<\/strong> \u2014 UBS Group AG initiated coverage with a Buy rating and a US$97.00 price target.<\/p>\n

Stanley Black & Decker (SWK)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to US$105.00 from US$110.00.<\/p>\n

State Street (STT)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to US$230.00 from US$220.00.<\/p>\n

State Street (STT)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$175.00 from US$196.00.<\/p>\n

State Street (STT)<\/strong> \u2014 Truist Financial Corporation maintained its Hold rating and lowered its price target to US$171.00 from US$190.00.<\/p>\n

Sterling Infrastructure (STRL)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to US$755.00 from US$754.00.<\/p>\n

Suja Life (SUJA)<\/strong> \u2014 Needham initiated coverage with a Buy rating.<\/p>\n

Sunoco (SUN)<\/strong> \u2014 Barclays PLC reiterated its Overweight rating and a US$83.00 price target.<\/p>\n

SunocoCorp (SUNC)<\/strong> \u2014 Barclays PLC reiterated its Overweight rating and a US$83.00 price target.<\/p>\n

Sutro Biopharma (STRO)<\/strong> \u2014 Wedbush reiterated its Outperform rating and a US$60.00 price target.<\/p>\n

Sweetgreen (SG)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$8.00 from US$7.00.<\/p>\n

Sysco (SYY)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$91.00 from US$88.00.<\/p>\n

Taiwan Semiconductor Manufacturing (TSM)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating and raised its price target to US$560.00 from US$530.00.<\/p>\n

Targa Resources (TRGP)<\/strong> \u2014 Jefferies Financial Group Inc. reiterated its Buy rating and a US$326.00 price target.<\/p>\n

Targa Resources (TRGP)<\/strong> \u2014 Scotiabank reiterated its Outperform rating and a US$319.00 price target.<\/p>\n

TechnipFMC (FTI)<\/strong> \u2014 Barclays PLC maintained its Overweight rating and lowered its price target to US$86.00 from US$87.00.<\/p>\n

Tenable (TENB)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$38.00 from US$35.00.<\/p>\n

Tetra Tech (TTEK)<\/strong> \u2014 KeyCorp reiterated its Overweight rating and its price target to US$41.00 from US$43.00.<\/p>\n

Tetra Tech (TTEK)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$44.00 from US$46.00.<\/p>\n

Teva Pharmaceutical Industries (TEVA)<\/strong> \u2014 Barclays PLC maintained its Overweight rating and raised its price target to US$47.00 from US$42.00.<\/p>\n

Texas Roadhouse (TXRH)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$221.00 from US$212.00.<\/p>\n

Texas Roadhouse (TXRH)<\/strong> \u2014 Stephens upgraded its rating to Overweight from Equal Weight with a US$205.00 price target.<\/p>\n

TFI International (TFII)<\/strong> \u2014 Scotiabank reiterated its Outperform rating.<\/p>\n

Thermo Fisher Scientific (TMO)<\/strong> \u2014 Guggenheim reiterated its Buy rating and a US$740.00 price target.<\/p>\n

Thermo Fisher Scientific (TMO)<\/strong> \u2014 Guggenheim reiterated its Buy rating and a US$740.00 price target.<\/p>\n

Thermo Fisher Scientific (TMO)<\/strong> \u2014 Royal Bank Of Canada set a US$740.00 price target.<\/p>\n

Toast (TOST)<\/strong> \u2014 Bank of America Corporation initiated coverage with a Buy rating and a US$40.00 price target.<\/p>\n

Toll Brothers (TOL)<\/strong> \u2014 Citigroup Inc. maintained its Buy rating and lowered its price target to US$168.00 from US$179.00.<\/p>\n

Toll Brothers (TOL)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$148.00 from US$158.00.<\/p>\n

Trane Technologies (TT)<\/strong> \u2014 Mizuho maintained its Neutral rating and raised its price target to US$485.00 from US$475.00.<\/p>\n

Transdigm Group (TDG)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$1,200.00 from US$1,350.00.<\/p>\n

Travel + Leisure (TNL)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to US$75.00 from US$95.00.<\/p>\n

Travel + Leisure (TNL)<\/strong> \u2014 The Goldman Sachs Group, Inc. reiterated its Buy rating and a US$78.00 price target.<\/p>\n

Ultragenyx Pharmaceutical (RARE)<\/strong> \u2014 UBS Group AG initiated coverage with a Neutral rating and a US$16.00 price target.<\/p>\n

Union Pacific (UNP)<\/strong> \u2014 Raymond James Financial, Inc. set a US$350.00 price target.<\/p>\n

uniQure (QURE)<\/strong> \u2014 UBS Group AG set a US$48.00 price target.<\/p>\n

United Therapeutics (UTHR)<\/strong> \u2014 The Goldman Sachs Group, Inc. reiterated its Sell rating and a US$368.00 price target.<\/p>\n

UnitedHealth Group (UNH)<\/strong> \u2014 Raymond James Financial, Inc. reiterated its Outperform rating and a US$450.00 price target.<\/p>\n

UnitedHealth Group (UNH)<\/strong> \u2014 TD Cowen reiterated its Hold rating and a US$402.00 price target.<\/p>\n

Upstart (UPST)<\/strong> \u2014 Citizens Jmp maintained its Market Underperform rating and lowered its price target to US$18.00 from US$20.00.<\/p>\n

US Foods (USFD)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$111.00 from US$107.00.<\/p>\n

V.F. (VFC)<\/strong> \u2014 Williams Trading set a US$22.00 price target.<\/p>\n

Vail Resorts (MTN)<\/strong> \u2014 Citigroup Inc. initiated coverage with a Market Perform rating.<\/p>\n

Vail Resorts (MTN)<\/strong> \u2014 Citizens initiated coverage with a Market Perform rating.<\/p>\n

Vail Resorts (MTN)<\/strong> \u2014 Citizens Jmp initiated coverage with a Market Perform rating.<\/p>\n

Varonis Systems (VRNS)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$53.00 from US$48.00.<\/p>\n

Veeva Systems (VEEV)<\/strong> \u2014 Oppenheimer Holdings, Inc. reiterated its Outperform rating and a US$325.00 price target.<\/p>\n

Verastem (VSTM)<\/strong> \u2014 Alliance Global Partners reiterated its Buy rating.<\/p>\n

Verastem (VSTM)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$24.00 from US$18.00.<\/p>\n

Verastem (VSTM)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating and its price target to US$19.00 from US$14.00.<\/p>\n

Verisk Analytics (VRSK)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating.<\/p>\n

Versant (VSNT)<\/strong> \u2014 Morgan Stanley initiated coverage with a Equal Weight rating and a US$38.00 price target.<\/p>\n

Vertiv (VRT)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to US$280.00 from US$300.00.<\/p>\n

Viking Therapeutics (VKTX)<\/strong> \u2014 UBS initiated coverage with a Buy rating and a US$94 price target.<\/p>\n

Viper Energy (VNOM)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$47.00 from US$46.00.<\/p>\n

Viper Energy Partners (VNOM)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Outperform rating and a US$54 price target.<\/p>\n

Visa (V)<\/strong> \u2014 BMO Capital Markets reiterated coverage.<\/p>\n

Vital Farms (VITL)<\/strong> \u2014 Stifel Nicolaus maintained its Hold rating and lowered its price target to US$9.00 from US$11.00.<\/p>\n

Voya Financial (VOYA)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to US$105.00 from US$109.00.<\/p>\n

Walmart (WMT)<\/strong> \u2014 Deutsche Bank upgraded its rating to Buy from Hold and set its price target to US$136.00 from US$113.00.<\/p>\n

Walmart (WMT)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft upgraded its rating to Buy from Hold and set its price target to US$136.00 from US$113.00.<\/p>\n

Waste Connections (WCN)<\/strong> \u2014 Scotiabank set a US$193.00 price target.<\/p>\n

Watsco (WSO)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to US$325.00 from US$350.00.<\/p>\n

WAVE Life Sciences (WVE)<\/strong> \u2014 UBS Group AG initiated coverage with a Buy rating and a US$11.00 price target.<\/p>\n

Weatherford International (WFRD)<\/strong> \u2014 Barclays PLC maintained its Overweight rating and lowered its price target to US$148.00 from US$151.00.<\/p>\n

Wendy’s (WEN)<\/strong> \u2014 Stephens maintained its Equal Weight rating and lowered its price target to US$7.00 from US$8.00.<\/p>\n

Wingstop (WING)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$202.00 from US$238.00.<\/p>\n

Wingstop (WING)<\/strong> \u2014 UBS Group AG reiterated its Neutral rating and a US$140.00 price target.<\/p>\n

Workday (WDAY)<\/strong> \u2014 Stifel Nicolaus maintained its Hold rating and raised its price target to US$175.00 from US$160.00.<\/p>\n

Workday (WDAY)<\/strong> \u2014 UBS Group AG set a US$175.00 price target.<\/p>\n

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (XNDU)<\/strong> \u2014 Morgan Stanley set a US$3.75 price target.<\/p>\n

Xcel Energy (XEL)<\/strong> \u2014 Barclays PLC maintained its Overweight rating and lowered its price target to US$85.00 from US$90.00.<\/p>\n

XPO (XPO)<\/strong> \u2014 Raymond James Financial, Inc. set a US$205.00 price target.<\/p>\n

Xylem (XYL)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to US$110.00 from US$130.00.<\/p>\n

YETI (YETI)<\/strong> \u2014 UBS Group AG set a US$44.00 price target.<\/p>\n

York Space Systems (YSS)<\/strong> \u2014 Piper Sandler initiated coverage with a Neutral rating and a US$9.00 price target.<\/p>\n

Zions Bancorporation, N.A. (ZION)<\/strong> \u2014 Robert W. Baird upgraded its rating to Outperform from Neutral with a US$75.00 price target.<\/p>\n

Zscaler (ZS)<\/strong> \u2014 Citigroup Inc. maintained its Buy rating and raised its price target to US$260.00 from US$245.00.<\/p>\n

ZTO Express (ZTO)<\/strong> \u2014 Goldman downgrade its Buy \u00bb Neutral rating.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) American analyst sentiment for October 15, 2026, shows a cautious but selectively optimistic market outlook, with 136 price target reductions outpacing…<\/p>\n","protected":false},"author":3,"featured_media":36666,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76279","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nUS Analyst Updates: October 15th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US Analyst Updates: October 15th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) American analyst sentiment for October 15, 2026, shows a cautious but selectively optimistic market outlook, with 136 price target reductions outpacing…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-15T21:20:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/07\/STA-Frame-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"34 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"US Analyst Updates: October 15th, 2026\",\"datePublished\":\"2026-10-15T21:20:05+00:00\",\"dateModified\":\"2026-10-15T21:20:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/\"},\"wordCount\":7666,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/\",\"name\":\"US Analyst Updates: October 15th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-15T21:20:05+00:00\",\"dateModified\":\"2026-10-15T21:20:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"US Analyst Updates: October 15th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"US Analyst Updates: October 15th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/","og_locale":"en_US","og_type":"article","og_title":"US Analyst Updates: October 15th, 2026","og_description":"Analyst Ratings (USA) American analyst sentiment for October 15, 2026, shows a cautious but selectively optimistic market outlook, with 136 price target reductions outpacing…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-15T21:20:05+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/07\/STA-Frame-3.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"34 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"US Analyst Updates: October 15th, 2026","datePublished":"2026-10-15T21:20:05+00:00","dateModified":"2026-10-15T21:20:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/"},"wordCount":7666,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/","name":"US Analyst Updates: October 15th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-15T21:20:05+00:00","dateModified":"2026-10-15T21:20:05+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-15th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"US Analyst Updates: October 15th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76279"}],"version-history":[{"count":10,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76279\/revisions"}],"predecessor-version":[{"id":76298,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76279\/revisions\/76298"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/36666"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}